Inhibikase Therapeutics Inc (IKT)
Cash & Equivalents
$31.21M
Quarterly · Period ending: · USD
IKT Cash & Equivalents
Latest reported$31.21Mperiod ending
Latest reported$31.21Mperiod ending
IKT Quarterly Cash & Equivalents (-$12.04K → $31.21M)
Quarterly Cash & Equivalents
High-resolution chart · PNG
IKT cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 31,206,707 | |
| 49,573,510 | |
| 139,220,208 | |
| 38,269,706 | |
| 77,742,669 | |
| 73,441,390 | |
| 56,490,579 | |
| 913,420 | |
| 3,086,455 | |
| 2,353,346 | |
| 9,165,179 | |
| 14,861,309 | |
| 1,905,108 | |
| 3,956,604 | |
| 7,188,553 | |
| 5,781,918 | |
| 32,212,276 | |
| 36,611,167 | |
| 40,750,133 | |
| 44,845,950 | |
| 46,836,556 | |
| 9,609,631 | |
| 13,953,513 | |
| 16,168 | |
| 7,785 | |
| 13,145 | |
| 18,457 | |
| -379,556 | |
| 379,557 | |
| 65,179 | |
| 16,665 | |
| -12,036 |